Vancouver, British Columbia (PRWEB) May 27, 2013
Ondine Biomedical Inc. announces that Dr. Titus Wong of the Vancouver Common Hospital, will be speaking at the Planet Congress of the International Photodynamic Association (IPA) on Might 28th through Might 31st, 2013. Dr. Wong will be describing the protocols and rewards of Photodisinfection. Dr. Wong and his team had been lately awarded the inaugural John Conly Innovation award at the 2012 AMMI-CACMID conference, recognizing a novel and creative strategy to enhance patient safety and public well being in Canada.

With growing worldwide recognition, MRSAid Photodisinfection Program has grow to be one of the most worthwhile technologies offered in stopping surgery-associated infections. Photodisinfection is a broad spectrum antimicrobial topical therapy that has been confirmed for decades to immediately and safely eradicate dangerous pathogens such as antibiotic resistant superbugs. Vancouver Common Hospital’s use of MRSAid’s innovative universal pre-surgical protocol resulted in a 39% reduction in surgical website infections and $ 1.9 million in cost savings.

The IPA Planet Congress is a biannual conference highlighting the advances in scientific and clinical investigation about the globe. This year’s Congress is being held Could 28th to Might 31st, 2013 at the Ritz-Carlton Hotel, Seoul, Korea. Worldwide leaders in the field of PDT and their perform will be represented throughout this occasion. Clinicians, scientists, researchers, hospital administrators, students are welcome to participate at this year’s conference.

About International Photodynamic Association

The IPA was founded in 1986 and its membership consists of the most prominent international clinicians and scientists involved in performing and researching photodynamic therapy (PDT) and photodiagnosis (PD). The objective of the IPA is to promote the study of diagnosis and treatment employing light and photosensitisers, to disseminate such details to the members of the IPA, the healthcare community and to the general public. The IPA organises an International Congress every two years to highlight leading investigation activities in the clinical and basic study aspects of PDT.

About Ondine Biomedical Inc.

Ondine is creating non-antibiotic therapies for the treatment of a broad spectrum of bacterial, fungal and viral infections. The Organization is focused on building major edge items utilizing its patented light-activated technologies. Photodisinfection provides broad-spectrum antimicrobial efficacy with out encouraging the formation and spread of antibiotic resistance. The Company is based in Vancouver, British Columbia, Canada, with Study and Development laboratories in Bothell, Washington, USA and Minneapolis, Minnesota. Please go to the Company’s internet site at: http://www.ondinebio.com and http://www.ondineblog.com. For further info please make contact with us at: Ondine Biomedical Inc. information(at)ondinebio(dot)com.